LCA COVID-19 Response shared by British Safety Council

The British Safety Council approached the LCA to write an article on re-opening buildings following the shutdown in response to COVID-19. The LCA provided a three page article for their Safety Management magazine that highlighted the risks associated with poor shutdown practices and how to safely re-open buildings to reduce the risk of Legionnaires disease.

Click here for a link to the full article.

The article highlights the importance of using LCA registered companies to assist in recommissioning buildings following am unexpected shutdown, such as COVID-19, managing a reduction in water usage in buildings through the application of filters for high risk areas and highlighting practical steps building owners can take such as reviewing their Legionella Risk Assessments on the back of the pandemic and reduced occupancy rates. 

Click here for the LCA COVID-19 response document.

By using LCA Members Services Provides end users, such as building owners, can have greater confidence in the quality of output provided by the Water Treatment/Hygiene company. The LCA externally audit all members annually in a range of areas including written procedures, staff training, competence assessments to ensure compliance to our standards that are references in the Approved Code of Practice for Legionella

The article closes with a comparison of the symptoms of Legionnaires disease against COVID-19 symptoms to highlight the close relationship the pair have been found to have in epidemiological studies. 

Comparison of Covid-19 and Legionnaires’ disease

 

Covid-19

Legionnaires’ disease

Symptoms

Fever or chills

Fever

 

Cough

Cough

 

Shortness of breath

Shortness of breath

 

Fatigue

Fatigue

 

Muscle or body aches

Muscle aches

 

Headache

Headache

 

Nausea or vomiting

Nausea

 

Diarrhoea

Diarrhoea

 

New loss of taste or smell

Delirium

 

Sore throat

 

 

Congestion or runny nose

 

 

Difficulty breathing

 

Increased susceptibility

Increasing age (>65)

Increasing age (>45)

 

Existing lung disease

Existing lung disease

 

Immunocompromised

Immunocompromised

 

Smokers

Smokers

 

Diabetics

Diabetics

 

Kidney disease

Kidney disease

 

Liver disease

Men (3 times more than women)

 

Moderate to severe asthma

 

 

Heart conditions

 

 

Obesity